Browsing: drug

With Valley fever cases climbing in California, physicians have struggled to treat the increasing number of patients grappling with the deadliest version of the disease. When Valley fever, or coccidioidomycosis, spreads from the lungs, it can cause infected joints, scarred lungs and even deadly meningitis. 

Weight-loss drug boom shifts costs to insurers and taxpayers – Earth.com 07-21-2026

Novo Nordisk A/S sued Eli Lilly & Co., accusing its rival of misleading advertising as competition in the U.S. market for obesity drugs ratchets up further

Ultomiris has become one of the most important treatments in the rare disease space because of its ability to reduce the burden of chronic infusion therapy while improving patient outcomes across paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), and generalized myasthenia gravis (gMG). As a long-acting C5 complement inhibitor, Ultomiris was developed as…

C-1101 is a potential first-in-class, disease-modifying, non-opioid therapy designed to address the underlying biology of chronic sciatica

ByLucy Notarantonio Newsweek is a Trust Project member See more of our trusted coverage when you search.to see more of our trusted coverage when you search.

ByLucy Notarantonio Newsweek is a Trust Project member See more of our trusted coverage when you search.to see more of our trusted coverage when you search.

Researchers at King’s College London have identified a promising new strategy for tackling Alzheimer’s disease by targeting several of the disease’s earliest biological changes at the same time. Their study found that KCL-286, an experimental drug originally developed for spinal cord injury that has already passed Phase 1 safety trials, reduced multiple hallmarks of Alzheimer’s…

(Catch all the Business News, Breaking News and Latest News Updates on The Economic Times.)

Alzheimer’s disease, which causes 60–80% of all dementia cases, is a progressive disease that affects memory, thinking and behavior, and there are currently few effective therapies